000 04188nam a22003975i 4500
001 289466
003 MX-SnUAN
005 20170705134219.0
007 cr nn 008mamaa
008 150903s2013 xxu| o |||| 0|eng d
020 _a9781607612599
_99781607612599
024 7 _a10.1007/9781607612599
_2doi
035 _avtls000343327
039 9 _a201509030846
_bVLOAD
_c201405050255
_dVLOAD
_y201402061153
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC870-923.2
100 1 _aKlein, Eric A.
_eeditor.
_9319699
245 1 0 _aManagement of Prostate Cancer /
_cedited by Eric A. Klein, J. Stephen Jones.
250 _a3rd ed. 2013.
264 1 _aTotowa, NJ :
_bHumana Press :
_bImprint: Humana Press,
_c2013.
300 _axii, 428 páginas
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aCurrent Clinical Urology
500 _aSpringer eBooks
505 0 _aEpidemiology and Risk Factors -- Twenty years and counting: is PSA still useful in 2010? -- Prostate Cancer Screening: A Review of the Evidence with Clinical Practice Implications -- Beyond PSA: Promising New Markers for Prostate Cancer -- Hereditary Prostate Cancer and Genetic Risk -- Prostate Inflammation and Prostate Cancer -- Molecular Progression of Prostate Cancer: Androgens and Estrogens -- The Role of Obesity and Diet in Prostate Cancer -- Prostate Cancer Risk Reduction by Chemoprevention -- Current Issues in Pathologic Evaluation -- Optimum Prostate Biopsy: Technique and Strategies -- The Utility of Nomograms in Routine Clinical Practice -- Active Surveillance Comes of Age -- Focal Therapy: Prostate Hemiablation as the First Historical Treatment Model for Focal Therapy of Early Stage Prostate Cancer -- Contemporary External Beam Radiotherapy -- Surgery, Brachytherapy, or  External Beam Radiation for Low and Intermediate-Risk Disease? -- The Role for Radical Prostatectomy in Advanced Prostate Cancer -- Radiation Therapy in the Management of Locally Advanced Prostate Cancer -- Clinical Implications of Measuring Quality-of-Life in Early Stage Prostate Cancer -- Treatment Modalities of Post-Prostatectomy Incontinence: A Historical Perspective As Well As Current  Therapy Options -- Management of Biochemical Recurrence After Localized Treatment for Prostate Cancer -- Management of Newly Diagnosed Metastatic Disease -- Pitfalls of Androgen Deprivation Therapy -- Current Management of Castration-resistant Prostate Cancer (CRPC) -- Radiopharmaceuticals and Bone Metastasis.
520 _aThe thoroughly updated and revised third edition of Management of Prostate Cancer provides concise and authoritative guidance to today's best therapeutic regimens for the diagnosis and treatment of prostate cancer.  Highlighting the latest major advances in the field, the book includes chapters on the most controversial areas of prostate cancer – screening, chemoprevention, and active surveillance; updated chapters on genetic risk and progression, biopsy schemes, treatment of complications, and comparative treatment outcomes for surgery; and new chapters on risk factors, new markers, nomograms, and focal therapy. This volume also features overviews of new and emerging drugs and treatment paradigms for castrate resistant disease, advances that promise to extend life and perhaps even cure a subset of men with metastatic disease. With its comprehensive illustrations and contributions from renowned experts in the field, Management of Prostate Cancer, 3rd Edition is an invaluable resource for practitioners in the treatment of prostate cancer.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aJones, J. Stephen.
_eeditor.
_9319544
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9781607612582
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-60761-259-9
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c289466
_d289466